NASDAQ · EQUITY · ENHANCED MARKET DYNAMICS

PBLS

Parabilis Medicines, Inc. Common Stock

US · Healthcare · Biotechnology

Open Chart Terminal

EMD SCORE41/100

CURRENT COMPLETED-WEEK READ

Cautious

The balance of evidence is weakening and risk control deserves more attention. Conditions are cautious and have weakened over the latest four completed weeks.

Deterioration50% directional agreement73/100 evidence quality5/6 sources available

Completed week: 9 Oct 2026
Latest close: USD 27.48
Evidence: 18 weeks

Four-week EMD change-14.6 pts

signed chart scale −100 to +100

Four-week price-25.5%

completed closing prices

Current directional run3 weeks

on the same side of EMD zero

Recent consistency7/13

recent readings above zero

COMPLETED-WEEK OVERVIEW

Price and market conditions over time

1 supportive · 3 cautious

Enhanced Market Dynamics and the price cycle18 completed weeks · bars use the left EMD axis; price uses the right axis.

12 Jun 2026–9 Oct 2026

Constructive EMDCautious EMDCompleted-week priceUp-cycle confirmationDown-cycle confirmation

Confirmation markers describe price-zone departures within this saved history. Earlier markers can change as the history changes; they are not a record of signals available in real time.

Cycle position 48%Current EMD -17.14-week EMD change -14.6Full saved history price range USD 25.85–41.73

View chart values · 18 observations

Week	Close · USD	EMD −100 to +100	Score /100	Agreement %	Coverage %
2026-06-12	27.26	-32.81	34	33	50
2026-06-19	25.85	-29.07	35	33	50
2026-06-26	28.80	-15.58	42	33	50
2026-07-03	29.58	-8.32	46	0	83
2026-07-10	30.57	-3.34	48	33	83
2026-07-17	29.55	-2.56	49	33	83
2026-07-24	31.28	-0.24	50	50	83
2026-07-31	33.98	4.34	52	50	83
2026-08-07	34.98	2.12	51	33	83
2026-08-14	37.07	3.13	52	33	83
2026-08-21	39.36	4.49	52	33	83
2026-08-28	39.11	2.66	51	33	83
2026-09-04	40.42	8.55	54	50	83
2026-09-11	36.88	-2.52	49	0	83
2026-09-18	41.73	20.08	60	50	83
2026-09-25	31.20	-17.61	41	33	83
2026-10-02	30.28	-10.37	45	50	83
2026-10-09	27.48	-17.14	41	50	83

SIX SOURCES · LAST 26 OBSERVATIONS

Is support broadening or thinning?

Green is supportive, rose is cautious.
Grey means the reading is unavailable.

Reading	12 Jun	19 Jun	26 Jun	3 Jul	10 Jul	17 Jul	24 Jul	31 Jul	7 Aug	14 Aug	21 Aug	28 Aug	4 Sep	11 Sep	18 Sep	25 Sep	2 Oct	9 Oct
Trend	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Momentum	—	—	—	50	73	74	69	75	75	78	78	77	79	69	81	44	40	31
Underlying pressure	—	—	—	50	50	50	50	50	50	50	50	50	50	50	50	50	50	50
Price & volume	33	40	58	55	49	48	57	62	54	56	55	48	61	36	90	13	41	30
Relative strength	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Modeled Trend	56	56	63	66	68	70	73	75	78	76	80	83	85	87	88	89	89	89

Each cell is a finished component score from 0–100. Components can disagree even when the combined reading stays positive.

STRONGEST CURRENT SOURCE

Modeled Trend

89/100

LEAST SUPPORTIVE SOURCE

Trend

0/100

WHAT WOULD CHANGE THE READ?

Three paths to keep in view

Conditional research scenarios.
No assumed price target or timing.

Continuation

Price and evidence stay together

Further price weakness alongside cautious trend, pressure and relative strength would support the current defensive read.

Change of direction

Repair needs follow-through

Improving EMD while price still falls is an early observation. A turn in price and broader agreement would strengthen a repair case.

Cycle context

A range extreme is a location

An upper zone can persist during a strong advance; a lower zone can persist during a decline. Use departures, EMD direction and the related price charts together.

EARLIER COMPARABLE READINGS

What followed similar conditions?

Same ticker · similar score and direction of change.
Returns exclude costs and dividends.

4 WEEKS LATER

Too few comparisons

0 non-overlapping examples. At least three are needed to display a summary.

13 WEEKS LATER

Too few comparisons

0 non-overlapping examples. At least three are needed to display a summary.

How these comparisons are selected

Earlier observations must have the same constructive/fading/repair/deterioration condition, a score within ten points of today’s score and at least the same component coverage. The first 30 observations are omitted for warm-up; examples are spaced by the forward horizon to avoid overlap. Gapped return windows are excluded. The all-period comparison uses the same available history and spacing, without matching the current state. These are reconstructed observations, not a point-in-time strategy backtest or a forecast.

THE FULL PRICE CYCLE

Follow the journey from one zone to the other

Cycle states use trailing completed-week observations.

Lower zone

Price establishes residence near the bottom of its long-cycle range. Improving EMD separates early repair from continued deterioration.

Upward journey

Price leaves the lower zone while EMD confirms improving participation. The objective is the broader move toward the upper zone, not a short weekly trade.

Upper zone

Price establishes residence near the top of its long-cycle range. A high range position can persist. Watch EMD for exhaustion and loss of support before interpreting it as a turn.

Downward journey

Price leaves the upper zone while EMD weakens. The reverse cycle remains active until lower-zone residence is confirmed again.

CURRENT READINGS